Why is Elanco Animal Health, Inc. ?
Unrated Stock - No Analysis Available
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Elanco Animal Health, Inc. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Elanco Animal Health, Inc.
132.1%
0.33
50.44%
S&P 500
16.12%
0.70
20.15%
Quality key factors
Factor
Value
Sales Growth (5y)
9.47%
EBIT Growth (5y)
18.65%
EBIT to Interest (avg)
0.90
Debt to EBITDA (avg)
5.95
Net Debt to Equity (avg)
0.62
Sales to Capital Employed (avg)
0.39
Tax Ratio
30.41%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
2.12%
ROE (avg)
2.44%
Valuation Key Factors 
Factor
Value
P/E Ratio
104
Industry P/E
Price to Book Value
1.72
EV to EBIT
62.87
EV to EBITDA
16.63
EV to Capital Employed
1.48
EV to Sales
3.30
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.35%
ROE (Latest)
1.65%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Movement
6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 629 MM
RAW MATERIAL COST(Y)
Fallen by -4.57% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at 52.14 %
DEBTORS TURNOVER RATIO(HY)
Highest at 4.89 times
-17What is not working for the Company
PRE-TAX PROFIT(Q)
Lowest at USD -27 MM
NET PROFIT(Q)
Lowest at USD -11 MM
EPS(Q)
Lowest at USD -0.07
Here's what is working for Elanco Animal Health, Inc.
Operating Cash Flow
Highest at USD 629 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Debt-Equity Ratio
Lowest at 52.14 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 4.89 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -4.57% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 176 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Elanco Animal Health, Inc.
Pre-Tax Profit
At USD -27 MM has Fallen at -116.64%
over average net sales of the previous four periods of USD 162.25 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -11 MM has Fallen at -108.95%
over average net sales of the previous four periods of USD 122.92 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Pre-Tax Profit
Lowest at USD -27 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -11 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
EPS
Lowest at USD -0.07
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)






